{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:48:54Z","timestamp":1787496534213,"version":"build-2736575974"},"reference-count":32,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2009,7,6]],"date-time":"2009-07-06T00:00:00Z","timestamp":1246838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2009,10]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Background\u2002<\/jats:bold>\n                    In Crohn\u2019s disease, anal ulcers and stricture can be disabling.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Aim\u2002<\/jats:bold>\n                    To evaluate long\u2010term outcome of non\u2010fistulizing perianal Crohn\u2019s disease under infliximab.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods\u2002<\/jats:bold>\n                    The medical records of 99 patients with non\u2010fistulizing perianal Crohn\u2019s disease at first infliximab infusion were reviewed. Complete responses (ulcer healing or stricture regression) after induction infliximab therapy and at the maximal follow\u2010up were assessed.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results\u2002<\/jats:bold>\n                    Ninety\u2010four patients (94.9%) had ulcers, 22 (22.2%) had stricture and 31 (31.3%) had draining perianal fistulas at first infliximab infusion. After infliximab induction therapy, 40\/94 (42.5%) patients with ulcers, 4\/22 (18.2%) with stricture and 10\/31 (32.2%) with fistulas had a complete response. Eight patients were lost to follow\u2010up. After a median follow\u2010up of 175\u2003weeks (range, 13\u2013459), complete response rates for ulcers, stricture and fistulas were 72.3% (68\/94), 54.5% (12\/22) and 54.8% (20\/31) respectively. Long\u2010term response for cavitating ulcer was positively associated with concomitant immunosuppressant use (\n                    <jats:italic>P<\/jats:italic>\n                    \u2003=\u20030.017) and older age (\n                    <jats:italic>P<\/jats:italic>\n                    \u2003=\u20030.049). Among the 12 patients with complete regression of stricture, 6 patients also had anal dilatation. Complete response was associated with perianal pain relief and disappearance of soiling. Three patients with ulcers developed an anal abscess.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions\u2002<\/jats:bold>\n                    Infliximab therapy may be effective in inducing and maintaining response for ulcers.\n                  <\/jats:p>","DOI":"10.1111\/j.1365-2036.2009.04089.x","type":"journal-article","created":{"date-parts":[[2009,7,6]],"date-time":"2009-07-06T20:22:27Z","timestamp":1246911747000},"page":"749-756","source":"Crossref","is-referenced-by-count":63,"title":["Long\u2010term outcome of non\u2010fistulizing (ulcers, stricture) perianal Crohn\u2019s disease in patients treated with infliximab"],"prefix":"10.1111","volume":"30","author":[{"given":"G.","family":"BOUGUEN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"TROUILLOUD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"SIPROUDHIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"OUSSALAH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.\u2010A.","family":"BIGARD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.\u2010F.","family":"BRETAGNE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"PEYRIN\u2010BIROULET","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,9,3]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastro.2003.08.025"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02058706"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02560279"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01648416"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199703000-00004"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02603444"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02048328"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800750120"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800750711"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03239.x"},{"key":"e_1_2_6_12_2","first-page":"121","article-title":"Cyclosporin treatment of anal and perianal lesions associated with Crohn\u2019s disease","volume":"14","author":"Cat H","year":"2003","journal-title":"Turk J Gastroenterol"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-004-0873-8"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.47.3.436"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20073"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(88)90243-0"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(89)90649-5"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02054120"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02049859"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.03.014"},{"key":"e_1_2_6_21_2","first-page":"949","article-title":"Infliximab therapy for Crohn\u2019s disease anoperineal lesions","volume":"25","author":"Ouraghi A","year":"2001","journal-title":"Gastroenterol Clin Biol"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.155812"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02253493"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.082909"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.12.019"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.09.002"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.35390"},{"issue":"1","key":"e_1_2_6_28_2","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.14309\/00000434-200809001-01117","article-title":"Sonic: a randomized, double\u2010blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn\u2019s disease naive to Immunomodulators and biologic therapy","volume":"103","author":"Sandborn W","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(80)90048-3"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.163642"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030815"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.10.047"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02878.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2009.04089.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2009.04089.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T16:14:01Z","timestamp":1697213641000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2009.04089.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,3]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.1111\/j.1365-2036.2009.04089.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2009.04089.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,3]]}}}